Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Alistair Nichol

Professor Alistair Nichol

Alistair Nichol

MB, BCh, BAO, BA (Health Scien), PhD, FRCARCSI, FJFICMI, FCICM


Professor of Critical Care Medicine

  • Honorary Visiting Research Fellow in Tropical Medicine
  • Prof (Chair) of Critical Care Medicine, University College Dublin, Ireland.
  • Prof, School of Public Health and Preventive Medicine, Monash University, Australia
  • Director, Irish Critical Care-Clinical Trials Network (ICC-CTN)
  • Deputy Director, Australia and New Zealand Intensive Care-Research Centre (ANZIC-RC)
  • Consultant Intensivist / Anaesthetist

Prof Alistair Nichol is the Chair of Critical Care Medicine in University College Dublin (UCD), the Director of the Irish Critical Care-Clinical Trials Network (ICC-CTN), Immediate Past Chair of the Irish Critical Care-Clinical Trials Group (ICC-CTG) and Deputy Director of the Australia and New Zealand Intensive Care-Research Centre (ANZIC-RC). Alistair is a Fellow (Honorary visiting) in Tropical Medicine at Oxford University, where he works with the International Severe Acute Respiratory Infection Consortium (SPRINT-SARI Project). Prof Nichol is a Consultant Intensivist / Anaesthetist at St. Vincent’s University Hospital in Dublin and in the Alfred Hospital in Melbourne.

Prof Alistair Nichol leads a program of critical care research nationally and globally having delivered some of the most pivotal clinical trials worldwide guiding clinical practice. His research focuses are pandemic preparedness and infectious disease (SPRINT-SARI, REMAP-CAP), brain injury (including TBI  and secondary brain injury post cardiac arrest) and general critical care (transfusion, renal replacement therapy, gastric prophylaxis). He also has a keen interest in biomarker and trials methodology research including SWATs. He leads a program of public and patient involvement and engagement activities.